Impact of Upadacitinib on Reducing Pain in Patients Across the Axial Spondyloarthritis Spectrum: A Post Hoc Analysis of the Phase 2/3 SELECT-AXIS Studies
Impact of Upadacitinib on Reducing Pain in Patients Across the Axial Spondyloarthritis Spectrum: A Post Hoc Analysis of the Phase 2/3 SELECT-AXIS Studies
Marina Magrey, Victoria S. Jasion, K. Kato, Ana Biljan et al.
Journal
Rheumatology and Therapy
Topics
Spondyloarthritis Studies and Treatments
article
Impact of Upadacitinib on Reducing Pain in Patients Across the Axial Spondyloarthritis Spectrum: A Post Hoc Analysis of the Phase 2/3 SELECT-AXIS Studies
Marina Magrey, Victoria S. Jasion, K. Kato, Ana Biljan, Ralph Lippe, Tianming Gao, Jamie Urbanik, Louis Bessette, Xenofon Baraliakos, Kurt de Vlam, Peter C. Taylor
article en
Abstract
No abstract available for this paper.
Publication Tag
Rheumatology and Therapy
Institutions
University Hospitals of Cleveland (US), Nuffield Orthopaedic Centre (GB), AbbVie (United States) (US), University of Oxford (GB), Rheumazentrum Ruhrgebiet (DE), Université Laval (CA), KU Leuven (BE)